AI News NQ Analysis

First OTC Approval! 'Rozerem® S', a Sleep Improvement Drug Containing Medical Ingredient 'Ramelteon', Receives Manufacturing and Marketing Approval

NQ Score 86/100
N1 Content Completeness 9

AI Summary (NQ-processed)

Alinamin Pharmaceutical has received manufacturing and marketing approval for 'Rozerem® S', the first OTC sleep improvement drug to contain the medical ingredient 'Ramelteon'. It is scheduled for release on July 28, 2026.

AI Analysis

Frequently Asked Questions

Q: When should I use Rozerem® S?
A: Use it when experiencing difficulty falling asleep due to temporary insomnia.
Q: Can anyone buy it?
A: It is a guidance-required drug and can be purchased after receiving an explanation from a pharmacist.
Q: How does it differ from other sleep aids?
A: It helps regulate the internal clock and guides the body toward natural sleep, similar to melatonin.